3.530USD+14.80%Mkt Cap: 168.40M USDP/E: —Last update: 2026-06-01
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that e…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap168.40M USD
Enterprise Value79.98M USD
Revenue (TTM)144.98M USD
Gross Profit64.72M USD
Net Income (TTM)-107.15M USD
Revenue/Share3.243 USD
Last Price3.530 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees450
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.25
PEG—
EV/EBITDA-1.26
EV/Revenue0.55
P/S0.99
P/B0.51
EPS (TTM)-2.35
EPS (Forward)-1.36
52W Range
2.39518% of range8.770
52W High8.770 USD
52W Low2.395 USD
Profitability
Gross Margin46.67%
Oper. Margin-59.12%
EBITDA Margin-43.92%
Profit Margin-77.28%
ROE-36.23%
ROA-25.59%
Growth
Revenue Growth20.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-77.24M USD
CapEx (TTM)2.61M USD
FCF Margin-15.16%
FCF Yield-13.05%
Net Debt-63.93M USD
Net Debt/EBITDA1.00
Balance Sheet
Debt/Equity0.13
Current Ratio3.72
Quick Ratio2.54
Book Value/Sh5.995 USD
Cash/Share2.107 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.333 USD
Target Range4.000 USD – 5.000 USD
# Analysts3
Ownership
Shares Out.47.11M
Float38.49M
Insiders6.24%
Institutions85.44%
Short Interest
Short Ratio3.7d
Short % Float12.31%
Short % Out.10.93%
Shares Short5.15M
Short (prev mo.)4.30M
Technical
SMA 503.289 (+7.3%)
SMA 2005.246 (-32.7%)
Beta1.15
S&P 52W Chg27.70%
Avg Vol (30d)1.33M
Avg Vol (10d)1.37M
Technical Indicators
RSI (14)52.8
MACD-0.1678
MACD Signal-0.2340
MACD Hist.+0.0662
BB Upper3.430 USD
BB Middle2.861 USD
BB Lower2.291 USD
BB Width39.85%
ATR (14)0.2670 USD
Vol Ratio (20d)0.41x